nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A novel histone deacetylase inhibitor TMU-35435 enhances etoposide cytotoxicity through the proteasomal degradation of DNA-PKcs in triple-negative breast cancer
|
Wu, Yuan-Hua |
|
2017 |
400 |
C |
p. 79-88 10 p. |
artikel |
2 |
A perillyl alcohol-conjugated analog of 3-bromopyruvate without cellular uptake dependency on monocarboxylate transporter 1 and with activity in 3-BP-resistant tumor cells
|
Chen, Thomas C. |
|
2017 |
400 |
C |
p. 161-174 14 p. |
artikel |
3 |
ATP-binding cassette transporters in tumor endothelial cells and resistance to metronomic chemotherapy
|
Hida, Kyoko |
|
2017 |
400 |
C |
p. 305-310 6 p. |
artikel |
4 |
Chitosan-modified PLGA nanoparticles tagged with 5TR1 aptamer for in vivo tumor-targeted drug delivery
|
Taghavi, Sahar |
|
2017 |
400 |
C |
p. 1-8 8 p. |
artikel |
5 |
DDX17 nucleocytoplasmic shuttling promotes acquired gefitinib resistance in non-small cell lung cancer cells via activation of β-catenin
|
Li, Kai |
|
2017 |
400 |
C |
p. 194-202 9 p. |
artikel |
6 |
Editorial Board
|
|
|
2017 |
400 |
C |
p. ii- 1 p. |
artikel |
7 |
Editorial – Metronomic chemotherapy
|
Kumar, M.N.V. Ravi |
|
2017 |
400 |
C |
p. 203- 1 p. |
artikel |
8 |
Featuring the Guest Editors
|
Ravi Kumar, M.N.V. |
|
2017 |
400 |
C |
p. 204- 1 p. |
artikel |
9 |
5-Fluorouracil targets histone acetyltransferases p300/CBP in the treatment of colorectal cancer
|
Du, Changzheng |
|
2017 |
400 |
C |
p. 183-193 11 p. |
artikel |
10 |
Fn14·TRAIL fusion protein is oligomerized by TWEAK into a superefficient TRAIL analog
|
Prigozhina, Tatyana B. |
|
2017 |
400 |
C |
p. 99-109 11 p. |
artikel |
11 |
GOT1-mediated anaplerotic glutamine metabolism regulates chronic acidosis stress in pancreatic cancer cells
|
Abrego, Jaime |
|
2017 |
400 |
C |
p. 37-46 10 p. |
artikel |
12 |
Hepatitis B virus PreS1 facilitates hepatocellular carcinoma development by promoting appearance and self-renewal of liver cancer stem cells
|
Liu, Zhixin |
|
2017 |
400 |
C |
p. 149-160 12 p. |
artikel |
13 |
Immunological, anti-angiogenic and clinical effects of intratumoral interleukin 12 electrogene therapy combined with metronomic cyclophosphamide in dogs with spontaneous cancer: A pilot study
|
Cicchelero, Laetitia |
|
2017 |
400 |
C |
p. 205-218 14 p. |
artikel |
14 |
In vitro and in vivo anti-uveal melanoma activity of JSL-1, a novel HDAC inhibitor
|
Wang, Yun |
|
2017 |
400 |
C |
p. 47-60 14 p. |
artikel |
15 |
LFG-500, a novel synthetic flavonoid, suppresses epithelial–mesenchymal transition in human lung adenocarcinoma cells by inhibiting NLRP3 in inflammatory microenvironment
|
Yang, Dan |
|
2017 |
400 |
C |
p. 137-148 12 p. |
artikel |
16 |
Metronomic chemotherapy and immunotherapy in cancer treatment
|
Chen, Yu-Li |
|
2017 |
400 |
C |
p. 282-292 11 p. |
artikel |
17 |
Metronomic chemotherapy and nanocarrier platforms
|
Abu Lila, Amr S. |
|
2017 |
400 |
C |
p. 232-242 11 p. |
artikel |
18 |
Metronomic chemotherapy: A potent macerator of cancer by inducing angiogenesis suppression and antitumor immune activation
|
Biziota, Eirini |
|
2017 |
400 |
C |
p. 243-251 9 p. |
artikel |
19 |
Metronomic chemotherapy for advanced breast cancer patients
|
Cazzaniga, Marina Elena |
|
2017 |
400 |
C |
p. 252-258 7 p. |
artikel |
20 |
Metronomic chemotherapy in head and neck cancer
|
De Felice, Francesca |
|
2017 |
400 |
C |
p. 219-222 4 p. |
artikel |
21 |
Metronomic chemotherapy in metastatic colorectal cancer
|
Woo, In Sook |
|
2017 |
400 |
C |
p. 319-324 6 p. |
artikel |
22 |
Metronomic S-1 dosing and thymidylate synthase silencing have synergistic antitumor efficacy in a colorectal cancer xenograft model
|
Abu Lila, Amr S. |
|
2017 |
400 |
C |
p. 223-231 9 p. |
artikel |
23 |
Metronomics in the neoadjuvant and adjuvant treatment of breast cancer
|
Munzone, Elisabetta |
|
2017 |
400 |
C |
p. 259-266 8 p. |
artikel |
24 |
microRNA-7 impairs autophagy-derived pools of glucose to suppress pancreatic cancer progression
|
Gu, Dian-na |
|
2017 |
400 |
C |
p. 69-78 10 p. |
artikel |
25 |
miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect
|
Li, Ling |
|
2017 |
400 |
C |
p. 89-98 10 p. |
artikel |
26 |
Myocyte enhancer factor 2D promotes colorectal cancer angiogenesis downstream of hypoxia-inducible factor 1α
|
Xiang, Junyu |
|
2017 |
400 |
C |
p. 117-126 10 p. |
artikel |
27 |
Naturally occurring anti-cancer agents targeting EZH2
|
Shahabipour, Fahimeh |
|
2017 |
400 |
C |
p. 325-335 11 p. |
artikel |
28 |
Potential role of metronomic chemotherapy in the treatment of esophageal and gastroesophageal cancer
|
Noronha, Vanita |
|
2017 |
400 |
C |
p. 267-275 9 p. |
artikel |
29 |
RCCD1 depletion attenuates TGF-β-induced EMT and cell migration by stabilizing cytoskeletal microtubules in NSCLC cells
|
Wu, Junyu |
|
2017 |
400 |
C |
p. 18-29 12 p. |
artikel |
30 |
Resistance to metronomic chemotherapy and ways to overcome it
|
Riesco-Martinez, Maria |
|
2017 |
400 |
C |
p. 311-318 8 p. |
artikel |
31 |
Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trial
|
Montagna, Emilia |
|
2017 |
400 |
C |
p. 276-281 6 p. |
artikel |
32 |
The dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine glioma
|
Miyahara, Hiroaki |
|
2017 |
400 |
C |
p. 110-116 7 p. |
artikel |
33 |
The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer
|
Brizzolara, Antonella |
|
2017 |
400 |
C |
p. 9-17 9 p. |
artikel |
34 |
The Hippo pathway in hepatocellular carcinoma: Non-coding RNAs in action
|
Shi, Xuan |
|
2017 |
400 |
C |
p. 175-182 8 p. |
artikel |
35 |
The potential clinical promise of ‘multimodality’ metronomic chemotherapy revealed by preclinical studies of metastatic disease
|
Kerbel, Robert S. |
|
2017 |
400 |
C |
p. 293-304 12 p. |
artikel |
36 |
The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence
|
Barnoud, Thibaut |
|
2017 |
400 |
C |
p. 30-36 7 p. |
artikel |
37 |
The second-generation ALK inhibitor alectinib effectively induces apoptosis in human neuroblastoma cells and inhibits tumor growth in a TH-MYCN transgenic neuroblastoma mouse model
|
Lu, Jiaxiong |
|
2017 |
400 |
C |
p. 61-68 8 p. |
artikel |
38 |
The simultaneous inhibition of the mTOR and MAPK pathways with Gnetin-C induces apoptosis in acute myeloid leukemia
|
Espinoza, J. Luis |
|
2017 |
400 |
C |
p. 127-136 10 p. |
artikel |